SLC7A5 and cancer: Previous studies have shown that loss of LAT1 causes various nervous system lesions,[13, 14] and some LAT1 inhibitors have been widely reported in cancer research.[26, 27] Therefore, we used an inhibitor rather than a specific knockout to inhibit LAT1.